These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 24398293)

  • 1. PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease.
    Dumont M; Stack C; Elipenahli C; Jainuddin S; Launay N; Gerges M; Starkova N; Starkov AA; Calingasan NY; Tampellini D; Pujol A; Beal MF
    FASEB J; 2014 Apr; 28(4):1745-55. PubMed ID: 24398293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease.
    Dumont M; Wille E; Stack C; Calingasan NY; Beal MF; Lin MT
    FASEB J; 2009 Aug; 23(8):2459-66. PubMed ID: 19346295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of PGC-1α expression by Alzheimer's disease-associated pathway: presenilin 1/amyloid precursor protein (APP)/intracellular domain of APP.
    Robinson A; Grösgen S; Mett J; Zimmer VC; Haupenthal VJ; Hundsdörfer B; Stahlmann CP; Slobodskoy Y; Müller UC; Hartmann T; Stein R; Grimm MO
    Aging Cell; 2014 Apr; 13(2):263-72. PubMed ID: 24304563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.
    Qin W; Haroutunian V; Katsel P; Cardozo CP; Ho L; Buxbaum JD; Pasinetti GM
    Arch Neurol; 2009 Mar; 66(3):352-61. PubMed ID: 19273754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer's disease.
    Aso E; Lomoio S; López-González I; Joda L; Carmona M; Fernández-Yagüe N; Moreno J; Juvés S; Pujol A; Pamplona R; Portero-Otin M; Martín V; Díaz M; Ferrer I
    Brain Pathol; 2012 Sep; 22(5):636-53. PubMed ID: 22188425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models.
    Gong B; Pan Y; Vempati P; Zhao W; Knable L; Ho L; Wang J; Sastre M; Ono K; Sauve AA; Pasinetti GM
    Neurobiol Aging; 2013 Jun; 34(6):1581-8. PubMed ID: 23312803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroacupuncture activates AMPKα1 to improve learning and memory in the APP/PS1 mouse model of early Alzheimer's disease by regulating hippocampal mitochondrial dynamics.
    Jia WW; Lin HW; Yang MG; Dai YL; Ding YY; Xu WS; Wang SN; Cao YJ; Liang SX; Wang ZF; Chen C; Liu WL
    J Integr Med; 2024 Sep; 22(5):588-599. PubMed ID: 39181774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
    Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
    J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGC-1α reduces Amyloid-β deposition in Alzheimer's disease: Effect of increased VDR expression.
    Wang J; Guo MN; Liu ZZ; Ma SF; Liu WJ; Qian JJ; Zhang WN
    Neurosci Lett; 2021 Jan; 744():135598. PubMed ID: 33373677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease.
    Pohland M; Pellowska M; Asseburg H; Hagl S; Reutzel M; Joppe A; Berressem D; Eckert SH; Wurglics M; Schubert-Zsilavecz M; Eckert GP
    Alzheimers Res Ther; 2018 Feb; 10(1):18. PubMed ID: 29433569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer's disease model.
    Katsouri L; Lim YM; Blondrath K; Eleftheriadou I; Lombardero L; Birch AM; Mirzaei N; Irvine EE; Mazarakis ND; Sastre M
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12292-12297. PubMed ID: 27791018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation.
    Chaturvedi RK; Calingasan NY; Yang L; Hennessey T; Johri A; Beal MF
    Hum Mol Genet; 2010 Aug; 19(16):3190-205. PubMed ID: 20529956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.
    Kocherhans S; Madhusudan A; Doehner J; Breu KS; Nitsch RM; Fritschy JM; Knuesel I
    J Neurosci; 2010 Jul; 30(27):9228-40. PubMed ID: 20610758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAK-Mediated Signaling Controls Amyloid Beta Overload, Learning and Memory Deficits in a Mouse Model of Alzheimer's Disease.
    Saleh B; Srikanth KD; Sneh T; Yue L; Pelech S; Elliott E; Gil-Henn H
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate treadmill exercise ameliorates amyloid-β-induced learning and memory impairment, possibly via increasing AMPK activity and up-regulation of the PGC-1α/FNDC5/BDNF pathway.
    Azimi M; Gharakhanlou R; Naghdi N; Khodadadi D; Heysieattalab S
    Peptides; 2018 Apr; 102():78-88. PubMed ID: 29309801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition.
    Dumont M; Ho DJ; Calingasan NY; Xu H; Gibson G; Beal MF
    Free Radic Biol Med; 2009 Oct; 47(7):1019-27. PubMed ID: 19596066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
    Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
    Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
    España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
    Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.
    Sheng B; Wang X; Su B; Lee HG; Casadesus G; Perry G; Zhu X
    J Neurochem; 2012 Feb; 120(3):419-29. PubMed ID: 22077634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.